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Abstract
Background: Although maternal nutrient status influences all aspects of fetal development including the brain, the
impact of micronutrient supplementation on the baby’s mental function is a topic of debate. This systematic
review assesses the effect of single and multiple micronutrient supplementation during pregnancy on offspring
mental development.
Methods: Eleven electronic literature databases were searched using key terms of various combinations and filter
string terms. Reference lists of articles selected for review were scanned for citations fitting the same inclusion
criteria. Each stage of the literature retrieval and review process was conducted independently by two reviewers.
The CONSORT checklist was used to assess study quality.
Results: A total of 1316 articles were retrieved from the electronic database search, of which 18 met the inclusion
criteria and were evaluated. The selected studies were randomized controlled trials published from 1983 to 2010,
with high variance in sample size, intervention type, and outcome measures. The median CONSORT score was 15
(range 12 - 19). Due to inconsistent interventions and outcome measures among the studies, no conclusive
evidence was found that enhancing the intrauterine environment through micronutrient supplementation was
associated with child mental development in a number of dimensions. There was some evidence to support n-3
fatty acids or multi-micronutrients having some positive effect on mental development, but the evidence for single
nutrients was much weaker.
Conclusions: The study of children’s mental outcomes as a function of prenatal supplementation is still relatively
new, but the results of this systematic review suggest that further work with multiple micronutrients and/or n-3
fatty acids should be conducted.
Background
Almost universally, governments and health profes-
sionals suggest that pregnant women take prenatal for-
mulas containing various micronutrients to ensure a
healthy pregnancy and healthy baby. In addition to
these general guidelines, the more specific use of B-vita-
mins (especially folic acid) is now commonly recom-
mended, as they reduce the risk of neural tube defects if
consumed during the periconceptional period. The
impact of such perinatal supplementation is well
described for variables involving physical health, includ-
ing birth outcomes, fetal growth, and infant physical
development [1,2]. For instance, a review by Shah et al.
[3] concluded that pregnant women supplemented with
multi-micronutrients had significantly lower risk for low
birth weight (though not for prematurity) compared to
women supplemented with only iron and folic acid.
Guidelines for prenatal supplementation are of consid-
erable importance beyond the immediate obstetrical
implications. The long-lasting health impact of the
intrauterine environment on the developing foetus has
become an area of investigation ever since Barker sug-
gested the link for cardiovascular disease and type II
diabetes [4]. One well-recognized component of the
intrauterine environment that is likely responsible for
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understood that maternal nutrient status can influence
fetal development in all phases, including brain develop-
ment, which would affect behaviour and cognitive func-
tion [5]. The support for an association between
gestational nutrition and brain development has been
particularly strong for iron, n-3 fatty acids, and folate
[6-8].
In summary, there is no debate about the contribution
of micronutrients to health, nor the importance of preg-
nant women eating well to maximize the outcomes for
their babies. Even the concept of micronutrient supple-
mentation for pregnant women appears to be a univer-
sally accepted practice, and is widely accepted as
‘insurance’ to prevent adverse perinatal outcomes, espe-
cially in those at risk for inadequate nutrient status due
to other health factors [9]. However, the two topics that
are still open to much investigation and debate are the
optimal content of micronutrient supplementation, and
whether there is a long-term impact on the baby’sm e n -
tal function.
The existing literature was systematically reviewed to
assess the impact of prenatal supplementation on off-
spring mental development, including cognitive develop-
ment, psychomotor abilities, intelligence, and behavior/
temperament. This systematic review focused specifically
on the effect of single and multiple micronutrient sup-
plementation during pregnancy on offspring mental
development.
Methods
Search Strategy
The search strategy selected randomized controlled
trials (RCTs) and cohort studies in humans, with Eng-
lish-only text, with no limitations set for date of publica-
tion. BL consulted a Research Librarian at the Centre
for Health and Policy Studies, Community Health
Sciences at the University of Calgary to develop the
search strategy, the inclusion/exclusion criteria, abstract
screening tool, keyword list, validated search filters, and
databases.
Eleven electronic literature databases were searched by
BL between 22 - 30 Dec. 2009: Medline/PubMed (1950
to November Week 3 2009), HealthStar (1966 to Nov.
2009), EMBASE (1980 to 2009 Week 52), PsychInfo
(1967 to Dec. week 4, 2009), CAB Nutrition Abstracts
(1973 to 2009 week 51), Cochrane Library (1991 to Nov.
2009), AMED (1985 to December 2009), ERIC (1965 to
Nov. 2009), CINAHL (to week of Dec. 22, 2009), Scopus
and Web of Science (to week of Dec. 22, 2009).
The search syntax included four key parts: 1) terms
defining the population of interest (pregnancy, pregnant
women, prenatal, perinatal, antenatal); 2) terms for
micronutrients (supplement, micronutrient, dietary
supplement, vitamin, mineral, folic acid/folate, iron,
iodine, B complex, B12, selenium, zinc, vitamin A, vita-
min D); 3) terms for developmental outcomes (infant
development, child development, mental development,
brain development, neurodevelopment, cognitive devel-
opment, psychomotor, IQ, behavior); and 4) terms for
study design (RCT, pseudo-experimental, clinical trial,
longitudinal cohort). Validated filters were used in the
search strategy to ensure that all possible design terms
for RCTs and cohort studies were used. The Cochrane
search filters were used for RCTs [10] and the BMJ
Knowledge filters were used for observational studies
[11,12].
In addition, reference lists of articles selected for
review were scanned for citations fitting the same inclu-
sion criteria. This process enabled the identification of
additional literature that may otherwise have been
missed in the database search.
An updated search was conducted August 9, 2010 to
look for articles published since the initial search. One
study was found [13] and was included in the review.
Inclusion Criteria
RCTs that investigated the effects of single or multi-
micronutrient supplementation during pregnancy on
child development (including mental, cognitive, psycho-
motor, intelligence and behavior) were included. Other
study designs such as pseudo-experimental and cohort
studies were excluded because only one of each of the
aforementioned designs was found and the application
of the CONSORT scoring (see section below on quality
appraisal) was inappropriate for comparison to RCTs.
Also, those reporting maternal nutrient intake or status
(but not supplementation) and the effects on pregnancy
or birth outcomes, and physical (but not mental) devel-
opment or growth were excluded.
Identified citations were assessed against the inclusion
criteria independently by two reviewers (BL and BK),
first using the titles, then using the abstracts, and finally
using the full text where there was disagreement. Seven
articles were not in agreement between the two
reviewers. Disagreement was resolved by discussion with
re-examination of the document, and a consensus was
reached. Following discussions, six of those seven were
excluded. Articles on visual development were included
after a review of the abstracts revealed that it was being
used as a measure of neural development.
Data Extraction and Quality Appraisal
Details of the studies were extracted by two reviewers
(BL and KW) and summarized in tables. Key data
elements extracted included subject and intervention
characteristics, and outcomes of interest. Data from
each accepted study were reviewed and extracted
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determined by using the revised CONSORT 25-item
checklist [14]. Consensus score was used for all analyses.
The intraclass correlation coefficient for inter-observer
agreement was calculated. Four CONSORT items were
excluded because they were not applicable (19 (Harms),
and 23 - 25 (Other information)), leaving a maximum
score of 21 for each study (one point for each CON-
SORT item satisfied). The items were not weighted
because the CONSORT statement is not a validated
instrument. The articles were rated “good” quality if the
score was ≥ 17 (meeting >80% of the checklist items),
“average” if the score was between 13 - 16 (meeting 60-
79% of the checklist items) and “poor” if ≤ 12 (meeting
<59% of the checklist items).
Results
A total of 1316 articles were retrieved from the electro-
nic database search, of which 18 met the inclusion cri-
teria and were included in the final review (Figure 1).
Three trials reported only on cognitive development
[15-17], three reported visual development outcomes
[18-20], one reported behavior and temperament alone
[21], and the remaining studies examined outcomes for
cognitive, psychomotor, behavior, visual and/or auditory
development (Table 1) in various combinations. The
outcome measure most widely used was the Bayley
Scales of Infant Development (seven studies) [22-28].
Given the heterogeneity of methods and outcome
measures in the studies reviewed, it was not feasible to
compare effect sizes or to perform a meta-analysis.
Study Characteristics
In general, the variability in this small set of papers was
unexpectedly high in virtually every dimension evalu-
ated. The 18 studies reviewed were published from 1983
to 2010, and included pregnant women from 14 differ-
ent countries (ranging from Australia to Tanzania),
varying across rural and urban settings in developing
and industrialized nations (Table 1). Sample size varied
from 29 to over 2000 participants. The offspring were
assessed from two months to nine years age.
The interventions (Table 2) ranged from a single
micronutrient (four studies) [21,22,29,30] to multi-
micronutrients of various combinations (six studies)
[13,24-28], as well as n-3 fatty acids in the forms of cod
liver oil (two studies) [15,16], blended fish oil (three stu-
dies) [20,23,31], docosahexaenoic acid (DHA) in cap-
sules (one study) [19], and DHA-containing cereal bars
(two studies) [17,18]. Of the six multi-micronutrient for-
mulas, no two were alike.
Exposure dose and time period also varied consider-
ably, although there was greater agreement about treat-
ment onset: most began prior to 26 weeks gestation.
Several studies failed to specify the rationale used for
the selection of the ingredients of their formula or the
dose [22].
Follow up period also varied greatly among studies,
from 60 days to 66 weeks for visual acuity tests, and 3
months to 7.5 years for developmental tests. A number
of studies had repeated follow up time points where
assessment was conducted. Some studies showed a posi-
tive outcome at one assessment time, and null outcome
at another time [18,26,27]. Outcome did not appear to
be associated with length of follow up period.
Quality of Reporting
The total scores on the CONSORT checklist ranged
from 12 [16,17] to 19 [26], with a mean score of 14.95 ±
1.80 (the maximum possible score was 21). The median
score was 15. Four studies had quality scores rated
“good”, 12 were rated “average”,a n dt w ow e r e“poor”.
The agreement between the pair of reviewers who inde-
pendently assessed the RCTs using the CONSORT
checklist was excellent [32] (ICC = 0.775; 95% CI =
0.491-0.910; P < 0.001).
The majority of studies did not meet the CONSORT
statement standards [14], and none of the studies
reported all 21 items assessed. For example, only seven
studies (38.9%) reported how sample size was deter-
mined, one of which determined sample size post hoc.
While all of the studies reviewed were reported as
RCTs, only 33% (n = 6) provided information on gen-
eration of the random allocation sequence, 22% (n = 4)
referred to concealment of the allocation sequence, and
11% (n = 2) described the implementation of the rando-
mization. Furthermore, only Judge et al. [17] and Innis
and Friesen [19] reported on all three items relating to
randomization, whereas nearly 70% (n = 12) of the
RCTs reviewed did not report any information regarding
randomization. Information on blinding after interven-
tion assignment was somewhat better reported, yet
38.9% (n = 7) of the studies still failed to mention who
was blinded to group assignment.
Of the four studies that rated “good” for quality, one
study on multivitamin-mineral supplementation
reported a positive outcome [26], and the other three
reported no effect [21,24,30]. Two studies on fish oil/
DHA that rated “poor” on quality [16,17] did report
positive outcomes. Thus, there was no consistency
between study quality and outcome.
Seven studies with a positive outcome had quality
scores between 12 to 19 [16-18,25-27,31]. Four of these
studies had fish oil/DHA as the intervention, and three
were multivitamin-minerals. Eleven studies had null or
negative outcomes, with quality scores ranging from 14
to 17. In these 11 studies, six used a single micronutri-
ent, four used fish oil/DHA, and one used multivitamin-
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ducted in Western “developed” countries, of which four
had positive outcomes and six had null/negative out-
comes; eight studies were from “developing” countries
in Asia, Eastern Europe, South America, and Africa, of
which four had positive outcomes and four had null/
negative outcomes. Quality scores for studies in “devel-
oped” countries ranged from 12 to 17, while for
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Figure 1 Selection of studies for systematic review of the effect of prenatal supplementation with micronutrients on infant/child
development.
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Reference Sample Outcomes Measures Intervention/Duration Results Quality
Score
Caulfield et
al. [13]
184 children (Peru) 1,3
(At 4-5 yrs)
Wechsler Preschool & Primary Scale of
Intelligence
Zinc + folic acid + iron vs. folic acid + iron only
10-14 weeks gestation to birth
∅ 1,3 15/21
Goodenough & Harris Draw-a-Person Test
Vineland Adaptive Behaviour Scales
Preschool Behaviour Questionnaire
Dunstan et
al. [31]
72 children (Australia) 1,2,3
(At 34 mo)
Griffiths Mental Development Scale Fish oil vs. olive oil
20 weeks gestation to birth
∅ 1,3
+2
16/21
Peabody Picture Vocabulary Test
Child Behavior Checklist
Hamadani
et al. [22]
168 children (Bangladesh) 1,2,3
(At 39 mo)
Bayley Scales of Infant Development Zinc vs. placebo
16 weeks gestation to birth
- 1,2
∅ 3
14/21
Wolke’s Behaviour Rating Scale (modified)
Helland et
al. [16]
84 children (Norway) 1
(At 4 yrs)
Kaufman Assessment Battery for Children Cod liver oil vs. corn oil
18 weeks gestation to three months post-birth
+ 1 12/21
Helland et
al. [15]
143 children (Norway) 1
(At 7 yrs)
Kaufman Assessment Battery for Children Cod liver oil vs. corn oil
18 weeks gestation to three months post-birth
∅ 1 15/21
Innis &
Friesen [19]
135 infants (British Columbia) 4
(At 60 d)
Teller Acuity Card Procedure DHA vs. corn/soybean oil
16 weeks gestation to birth
∅ 4 16/21
Joos et al.
[25]
99 infants
(rural Taiwan)
1,2
(At 250 d)
Bayley Scales of Infant Development HCHP drink + MVM vs. LCLP drink + MVM
Preconception to lactation
∅ 1
+2
15/21
Judge et al.
[18]
30 infants (Connecticut) 4
(At 4 and 6
mo)
Teller Acuity Card Procedure DHA vs. corn oil cereal bar
24 weeks gestation to birth
+ 4 at 4
months
∅ 4a t6
months
14/21
Judge et al.
[17]
29 infants (Connecticut) 1
(At 9 mo)
Willatts’ Infant Planning Test
a DHA vs. corn oil cereal bar
24 weeks gestation to birth
+1
a
∅ 1
b
12/21
Fagan Test of Intelligence
b
Li et al. [26] 1305 infants
(rural China)
1,2
(At 3,6,12
mo)
Bayley Scales of Infant Development MVM vs. folic acid + iron vs. folic acid alone
14 weeks gestation to birth
+ 1 at 12
months
∅ 1 at 3 and
6 months
∅ 2
19/21
Malcolm et
al. [20]
55 infants (Scotland) 4
(At 50 and
66 wk)
Visual evoked potential Fish oil vs. sunflower oil
15 weeks gestation to birth
∅ 4 15/21
McGrath et
al. [27]
327 children born to HIV-
infected mothers (Tanzania)
1,2
(At 6, 12
and 18 mo)
Bayley Scales of Infant Development Vitamin A vs. MVM-A vs. MVM+A vs. placebo
<28 weeks gestation to 18 months post-birth
∅ 1
+ 2 (MVMs
only)
13/21
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2Table 1 Summary of measures, results, and quality scores of articles included in systematic review (Continued)
Parsons et
al. [21]
264 children (Australia) 3
(At 7.5 yrs)
Strengths and Difficulties Questionnaire Iron vs. placebo
20 weeks gestation to birth
∅ 3 17/21
Short Temperament Scale for Children
Schmidt et
al. [28]
276 infants
(rural Indonesia)
1,2
(At 6 and
12 mo)
Bayley Scales of Infant Development Iron + folic acid + vitamin A vs. iron + folic acid vs. LD iron + LD
folic acid
20 weeks gestation to birth
∅ 1, 2 14/21
Tamura et
al. [29]
355 children (Alabama) 1,2,4,5
(At 5.3 yrs)
Differential Ability Scales Zinc vs. placebo
20 weeks gestation to birth
∅ 1,2,4,5 15/21
Wide Range Achievement Test
Knox Cube test
Gross Motor Scale
Grooved Pegboard test
Peabody Picture Vocabulary Test
Visual Sequential Memory
Auditory Sequential Memory
Tofail et al.
[23]
249 infants (Bangladesh) 1,2,3
(At 10 mo)
Bayley Scales of Infant Development Fish oil vs. soy oil
25 weeks gestation to birth
∅ 1,2,3 15/21
Wolke’s Behaviour Rating Scale
Tofail et al.
[24]
2116 infants (Bangladesh) 1,2
(At 7 mo)
Willatts’ Infant Planning Test Food packets + MVM vs. food packets + iron + folic acid (Fe60)
vs. food packets + LD iron + folic acid (Fe30)
<30 weeks gestation to birth
∅ 1,2 17/21
Bayley Scales of Infant Development -
Psychomotor Developmental Index
Zhou et al.
[30]
302 children (Australia) 1,3
(At 4 yrs)
Stanford-Binet Intelligence Scale Strengths
and Difficulties Questionnaire
Iron vs. placebo
20 weeks gestation to birth
∅ 1,3 17/21
1 = cognitive development
2 = motor development
3 = behavioral development
4 = visual development
5 = auditory development
∅ = no effect of nutrient(s) on development
+ = positive effect of nutrient(s) on development
- = negative effect of nutrient(s) on development
MVM = multivitamin-mineral
HCHP = high calorie, high protein
LCLP = low calorie, low protein
MVM-A = multivitamin-mineral without vitamin A
MVM+A = multivitamin-mineral with vitamin A
LD = lower dosage
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2Table 2 Composition of (daily) micronutrient, macronutrient and fatty acid interventions in studies included in the systematic review
Vit. A (mcg
RAE)
B1
(mg)
B2
(mg)
B3
(mg)
B6
(mg)
B12
(mcg)
Folic acid
(mg)
Vit. C
(mg)
Vit. D
(IU)
Vit. E
(mg)
Iron
(mg)
Zinc
(mg)
Cu
(mg)
I
(mcg)
Se
(mcg)
DHA
(g)
EPA
(g)
Caulfield et al. [13]
“zinc + iron + folic acid”
- - - - - - 250 - - - 60 25 - - - - -
Caulfield et al. [13]
“iron + folic acid”
- - - - - - 250 - - - 60 - - - - - -
Dunstan et al. [31] - - - - - - - - - 12 - - - - - 2.2 1.1
Hamadani et al. [22] - - - - - - - - - - - 30 - - - - -
Helland et al. [15,16] 1170 - - - - - - - 400 14 - - - - - 1.2 0.8
Innis & Friesen [19] - - - - - - - - - - - - - - - 0.4 -
a,bJoos et al. [25]
“HCHP drink”
1500 1.6 1.8 20.0 1.6 2.0 - 75 400 6.7 12 - 1.0 - - - -
bJoos et al. [25]
“LCLP drink”
** * * * ** * * * * * * * * - -
cJudge et al. [17,18] - - - - - - - - - - - - - - - 0.2 -
Li et al. [26]
“MVM”
800 1.4 1.4 18 1.9 2.6 0.4 70 200 10 30 15 2.0 150 65 - -
Li et al. [26]
“iron + folic acid”
- - - - - - 0.4 - - - 60 - - - - - -
Li et al. [26]
“folic acid”
- - - - - - 0.4 - - - - - - - - - -
Malcolm et al. [20] - - - - - - - - - - - - - - - 0.2 -
dMcGrath et al. [27]
“vitamin A”
6000 - - - - - - - - - - - - - - - -
McGrath et al. [27]
“MVM-A”
- 20 20 100 25 50 0.8 500 - 30 - - - - - - -
dMcGrath et al. [27]
“MVM+A”
6000 20 20 100 25 50 0.8 500 - 30 - - - - - - -
Parsons et al. [21] - - - - - - - - - - 20 - - - - - -
Schmidt et al. [28]
“iron + folic acid +
vitamin A”
4800 - - - - - 0.5 - - - 120 - - - - - -
Schmidt et al. [28]
“iron + folic acid”
- - - - - - 0.5 - - - 120 - - - - - -
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2Table 2 Composition of (daily) micronutrient, macronutrient and fatty acid interventions in studies included in the systematic review (Continued)
Schmidt et al. [28]
“LD iron + LD folic acid”
- - - - - - 0.25 - - - 90 - - - - - -
Tamura et al. [29] - - - - - - - - - - - 25 - - - - -
Tofail et al. [23] - - - - - - - - - - - - - - - 1.2 1.8
eTofail et al. [24]
“food + MVM”
800 1.4 1.4 18 1.9 2.6 0.4 70 200 10 30 15 2 150 65 - -
eTofail et al. [24]
“food + Fe60”
- - - - - - 0.4 - - - 60 - - - - - -
eTofail et al. [24]
“food + Fe30”
- - - - - - 0.4 - - - 30 - - - - - -
Zhou et al. [30] - - - - - - - - - - 20 - - - - - -
*Nutrient content not quantified in study protocol
Additional compositions:
aJoos et al. [25] - calcium 1000 mg, phosphorus 800 mg, sodium 400 mg, potassium 1.8 g, manganese 2 mg, fibre 1.1 g, 800 kcal, protein 40 g
bJoos et al. [25] - additional vitamins and minerals provided by multivitamin-mineral tablet were unspecified
cJudge et al. [17,18] - 70 kcal, protein 1 g, carbohydrate 15 g
dMcGrath et al. [27] - vitamin A dose provided as 30 mg beta-carotene (4500 mcg RAE) and 5000 IU (1500 mcg RAE) preformed vitamin A
eTofail et al. [24] - quantity of daily protein provided by food packets was unspecified
Abbreviation definitions:
Vit. = vitamin
B1 - Thiamine
B2 - Riboflavin
B3 - Niacin
B6 - Pyridoxine
B12 - Cobalamine
Cu - Copper
I - Iodine
Se - Selenium
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2“developing” countries, the range was 13 to 19. Out-
come did not appear to be associated with location of
the study.
Mental Development Outcomes
Three trials reported improvements in cognitive devel-
opment, each with different single and multi-nutrient
supplements [16,17,26], yet the improvements were
transient with respect to age groups tested in two of the
studies. There was no consistency among these reports
regarding the specific aspect of cognitive development
that improved, whether processing, problem solving or
overall cognitive development.
Psychomotor outcomes were improved in three stu-
dies: two involving multivitamin-mineral supplements
[25,27], and one with fish oil capsules [31]. Both the
multivitamin-mineral supplement studies found
improved psychomotor scores using the Bayley Scales of
Infant Development, whereas the study on fish oil [31]
found improvements in hand-eye coordination.
There were no trials reporting significant differences
between treatment and placebo groups among those
assessing behavior or temperament. Visual development
was improved in one study using DHA supplementation
[18]; however, improvement in visual acuity was seen at
four but not at six months of age. All other studies
investigating visual development had null results.
Negative effects on developmental outcomes were
reported in a small number of studies. Hamadani et al.
[22] found that children whose mothers were supple-
mented with zinc prenatally scored lower on cognitive
and psychomotor indices. Similarly, two studies which
examined the effects of iron on neurodevelopment
[21,30] found higher, but non-significant, rates of abnor-
mal behavior and peer problems in iron-supplemented
groups compared with placebo, though this was only in
a small subsample from each study.
Discussion
Principal Findings
This systematic review revealed no conclusive evidence
that an enhanced intrauterine environment through
nutrient supplementation was associated with better
mental development in the child. While cognitive, psy-
chomotor and visual function showed improved out-
comes with supplementation in several studies, the
findings were often transient (not detectable when chil-
dren were tested later in life) with poor corroboration
among studies.
Though not conclusive, there was some evidence to
support supplementation with n-3 fatty acids or multiple
(but not single) micronutrients having some positive
effect on mental development. Among the n-3 fatty acid
intervention studies, four reported higher scores in one
or more outcome measure in the intervention group
compared to the placebo group [16-18,31], while four
studies found no difference between the groups
[15,19,20,23]. There were significant methodological
limitations in some of the studies with no results, which
may be responsible for the null findings. For instance,
there was poor compliance with the n-3 fatty acid cap-
sules in the study by Tofail et al. [23], and there was sig-
nificant contamination in the ‘placebo’ group used by
Helland et al. [15,16], in that approximately 50% of chil-
dren, regardless of group assignment, consumed cod
liver oil regularly during the preschool years. Also, the
dose and formulation employed by two of the studies
[19,20] was relatively low at 200 mg of only DHA.
There is epidemiologic evidence that maternal dietary
n-3 fatty acid intake influences mental development. For
example, Gale et al. [33] used the Strength and Difficul-
ties Questionnaire and Wechsler Abbreviated Scale of
Intelligence to examine the association between fish
intake in pregnant women and their children’s IQ at age
9. Compared to mothers who did not eat oily fish dur-
ing gestation, there was a reduced risk of hyperactivity
in children whose mothers had eaten oily fish in early
pregnancy and higher verbal IQs in those whose
mothers ate fish in late pregnancy
Among the vitamin and mineral studies reviewed here,
better cognitive and/or psychomotor outcomes were
reported for supplementation when the intervention
involved multiple micronutrients [25-27]. In contrast,
the results for single micronutrient supplementation of
pregnant women on child neurodevelopment were null
for iron [21,30], folic acid [28], vitamin A [28], and zinc
[13,29]. The positive findings with respect to multi-
nutrient supplementation are supported in the literature.
Wehby and colleagues [34], using survey data, found
that prenatal multivitamin-mineral use was associated
with reduced risk of language and social development
delays during childhood, whereas single micronutrients
showed variable effects, several of which were negatively
associated with developmental outcomes.
Other correlational and epidemiologic studies of
maternal nutrient status and child development have
reported mixed and inconsistent results. Bhate et al.
[35] did a follow-up comparison of cognitive function in
9-year-old children, and found that children of women
with high plasma B12 during pregnancy performed sig-
nificantly better on the Color Trail Test (subtest A) and
Digit Span Test (backward), but not on the Raven’s
Colored Progressive Matrices and Visual Recognition
tests. However, another follow-up study compared cog-
nitive development in 5-year-old children as a function
of maternal folate status during pregnancy, finding no
differences in the test scores of neurodevelopment
between the low folate and normal folate groups [36].
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to be associated with infant outcomes in terms of physi-
cal health, and perhaps some indicators of mental func-
tion, should broader supplementation guidelines be
considered? A number of studies have found nutrient
inadequacies in pregnant women living in western coun-
tries consuming a typical western diet [37]. A study by
Ray et al. [38] reported that after a decade of folic acid
fortification, other B-vitamin deficiencies, such as B12,
continue to occur in up to five percent of pregnant
women. These authors concluded that B12 deficiency
may be an independent risk factor for neural tube
defect. Thus, even in developed, nutritionally-abundant
countries, nutrient inadequacy or deficiency may be
more common than realized.
Another aspect of nutrient requirement not consid-
ered is genetic variance. A report by Cavalli et al. [39]
discussed the “folic resistance” hypothesis among some
women. That is, while prenatal folic acid supplementa-
tion prevented about 70% of neural tube defects in one
dataset [40], there are cases of folate-resistant and
folate-sensitive NTD subtypes, which are supported by
animal models [39]. In a case series, Cavalli and collea-
gues [39] supplemented women with high NTD recur-
rence risk with periconceptional inositol and folic acid
to prevent reputed folate-resistant fetal NTDs. The addi-
tion of inositol to folic acid appeared to prevent the
recurrence of NTDs in subsequent pregnancies and
deliveries. Thus, this is further evidence that multi-
micronutrient supplementation during pregnancy may
confer greater benefit than single nutrient supplementa-
tion for infant outcomes.
Limitations of Current Evidence
The primary limitations were related to the methodolo-
gies and reporting of the 18 studies included in this
review: unclear recruitment, randomization, blinding,
follow up, unclear or unspecified supplement dosage
and reason for dosage setting, and lack of monitoring or
reporting of compliance. Other limitations we noted
were small sample size, variability of follow-up periods,
and inadequate information regarding factors such as
home environment, education, and level of stimulation.
These social and educational variables are important in
that the children were exposed to them between birth
and the time of final assessment, hence influencing out-
comes. Another design deficiency across the studies is
the lack of measurement for dietary intake and/or nutri-
ent status of the women prior to supplementation. This
i n f o r m a t i o nw o u l db eav a l u a b l eb a s e l i n ef o ra s s e s s i n g
whether the adequacy of women’s intake or status was
relevant to supplementation outcomes.
There is also some question regarding the selection of
placebos used in the n-3 fatty acid intervention studies.
While a true placebo is biologically inert, n-3 fatty acid
intervention studies provide the control groups with
metabolically-active compounds in order to maintain
visual appearance, namely oils with varying concentra-
tions of fatty acids. One could argue that these oils can-
not serve as a control supplement given their distinct
effect on maternal lipid and fatty acid profiles [41]. This
use of metabolically active ‘placebos’ leads to uncertainty
as to whether differences reported between n-3 fatty
acids and ‘placebo’ groups can be attributed solely to
increased n-3 fatty acid intake.
Few studies provided information pertaining to diet
quality, whether by assessing nutrient status with blood
samples or dietary intake through recalls or question-
naires. Thus, the adequacy of prenatal nutrient status
was not known, limiting conclusions about how baseline
dietary intake and status may affect infant mental devel-
opment in supplementation trials. It is possible that if a
woman has widespread nutrient deficiencies, supple-
menting with a single nutrient would not have any
noticeable impact on the offspring’s mental develop-
ment, perhaps accounting for why multi-micronutrient
supplements appeared to be associated with better
outcomes.
Given the variability in study populations, interven-
tions used, outcomes measured, and the overall low
reporting quality of the studies, our findings cannot
answer our a priori question nor be generalized to a
broader population. This inconsistency among the stu-
dies is reflected in the low CONSORT scores. The use
of the CONSORT checklist to evaluate studies may not
always provide an adequate appreciation of rigor,
because low scores may be at least partly explained by
the historical focus of CONSORT - pharmaceutical and
treatment-based RCTs; thus, the applicability of CON-
SORT to RCTs of a non-pharmaceutical nature is
unclear. However, the use of a checklist like the CON-
SORT provided a means to assess consistency of the
studies in this systematic review, and highlighted a num-
ber of limitations that made interpretation problematic.
Strengths and Weaknesses of the Systematic Review
The initial search criteria employed here included only
English language articles, and RCTs, pseudo-experimen-
tal and cohort studies, which may have resulted in miss-
ing some pertinent studies. Since much of the literature
on the topic of gestational nutrition emerges from the
developing world, the loss of some of the non-English
literature may limit the generalizability of the conclu-
sions that were drawn. Another limitation is publication
bias: studies with null result may be less likely to be
published, and would not be included in this review.
The fact that a meta-analysis was not feasible is also a
weakness that could not be overcome given the present
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other hand, this systematic review appears to be the first
attempt to evaluate objectively the literature that is
beginning to develop on the topic of prenatal supple-
mentation and children’s mental outcomes. Although
many of the studies were published prior to the devel-
opment of current methodologic standards (e.g., the
CONSORT guidelines) and hence cannot be faulted for
the weaknesses they manifest, the tabular presentation
of those weaknesses at this point in time may be useful
for guiding future studies in this area.
Conclusions
This review attempted to assess the state of evidence for
the relationship between prenatal supplementation and
infant mental development. We recognize that infant men-
tal development is the result of complex multifactorial
processes. Nutrients form the bases for proper neural
development and could have long-lasting impact on men-
tal development later in life. Given that pregnant women
are often told by primary clinicians to incorporate folate
(with or without B12) and/or iron into their diet, it is
important to know that the research seems to indicate
that single nutrient supplementation is less adequate than
supplementation with more complex formulas. This find-
ing was derived from studies from both developed and
developing countries. Although not conclusive at this
stage, the evidence suggestst h e r ei sv a l u ei nf u r t h e r
research examining the potential benefit of prenatal multi-
micronutrient and n-3 fatty acid supplementation for child
mental development. Future studies should consider the
timing, duration, and required dosage of supplementation
that meets the needs of the developing foetus to fully
examine the impact of multi-micronutrients (including n-
3 fatty acid) on child mental development.
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